Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EN3835 Long-Term Extension in Plantar Fibromatosis
NCT05254457Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Feb 2022
- Primary completion
- Mar 2024
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of collagenase clostridium histolyticum in plantar fibromatosis, sponsored by Endo International plc. Started Feb 2022; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
plantar fibromatosis
Beyond the preview
Go deeper on NCT05254457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05254457.